Physician profile
Brian Mccroskey
NPI 1407851066
$35,451.01
in general payments reported to CMS, 2019-2025
39 companies · $2,930 in 2025
The $2,930 reported for 2025 was more than what 77% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $1,013 · 2021: $1,710 · 2022: $3,213 · 2023: $2,890 · 2024: $3,707 · 2025: $2,930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $4,193 · Food and Beverage: $3,467 · Travel and Lodging: $1,866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $4,193.33 |
| Food and Beverage | $3,467.44 |
| Travel and Lodging | $1,865.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,410.71 | 2019-2020 | |
| Medtronic, INC. | $4,854.29 | 2021-2024 | Venaseal, Hawkone, Endurant Iis |
| Angiodynamics, INC. | $4,235.49 | 2021-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Silk Road Medical, INC. | $2,012.57 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Boston Scientific Corporation | $1,590.43 | 2019-2025 | Varithena Administration Pack |
| W. L. Gore & Associates, INC. | $1,570.38 | 2019-2025 | Gore Excluder Aaa Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Endologix LLC | $1,283.43 | 2019-2023 | Alto Abdominal Stent Graft System |
| Medtronic Vascular, INC. | $675.75 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $564.46 | 2019-2022 | |
| Lemaitre Vascular, INC. | $250.44 | 2019-2022 | |
| Abbott Laboratories | $245.09 | 2021 | |
| Penumbra, INC. | $237.48 | 2019-2024 | Indigo System |
| Shockwave Medical, INC | $195.57 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Davol INC. | $170.43 | 2020-2022 | |
| Next Science LLC | $160.27 | 2024 | Surgx, Blastx, Xperience |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surmodics, INC. | $157.18 | 2025 | Pounce Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy |
| Philips North America LLC | $125.18 | 2021 | |
| Organogenesis INC. | $73.25 | 2019-2022 | |
| Ethicon US, LLC | $73.05 | 2019 | |
| Terumo Medical Corporation | $66.08 | 2022 | |
| Cardiva Medical, INC. | $57.60 | 2022 | |
| Bolton Medical INC | $45.60 | 2019 | |
| Medistim USA, INC. | $43.80 | 2022 | |
| Tactile Systems Technology INC | $43.76 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Medline Industries Lp | $37.85 | 2019 | |
| Hologic Sales and Service, LLC | $31.75 | 2024 | Coolseal Generator |
| Cook Medical LLC | $30.36 | 2019-2023 | Cook Celect |
| Merck Sharp & Dohme LLC | $25.75 | 2019-2021 | |
| Biocompatibles, INC. | $24.76 | 2019 | |
| Tela Bio, INC. | $22.36 | 2019 | |
| Bioventus LLC | $20.38 | 2025 | Xcell |
| Molnlycke Health Care US, LLC | $17.95 | 2021 | |
| Allergan, INC. | $17.26 | 2019 | |
| Avinger INC. | $16.66 | 2019 | |
| Smith+Nephew, INC. | $15.22 | 2022 | |
| Abbvie INC. | $14.22 | 2021 | |
| Acera Surgical, INC. | $12.78 | 2019 | |
| Venturemed Group, INC. | $12.72 | 2021 | |
| Z-Medica, LLC | $8.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mccroskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.